Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 20Terminated 3Active not recruiting 3Withdrawn 1Unknown 1No longer available 1

Sponsor Class

OTHER 14INDUSTRY 3NIH 2NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 2Advanced Prostate Cancer 1

Interventions

pembrolizumab 184Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 54fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 40Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × bicalutamide × Clear all
NCT03971110 2022-12-16

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

AstraZeneca

Phase 4 Terminated
9 enrolled
Genitourinary

Advanced Prostate Cancer

NCT00831233 2013-11-11

Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Ferring Pharmaceuticals

Phase 3 Terminated
42 enrolled 22 charts
Genitourinary

Prostatic Neoplasms

NCT00514917 2013-11-04

Rising PSA

Sanofi

Phase 3 Terminated
413 enrolled 21 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡